Documents CytoSorb and COVID-19

Hi everyone,

Enclosed already now (many thanks to all involved in the rapid approval) the rationale and the options for action when using CytoSorb in COVID-19 patients. These can be shared with interested physicians and distributors. You will find these two documents together with the current recommendations of the Italian Society of Nephrology at our website:

B1115R01ENG2020_Options_for_actions_Cytosorb_COVID19_English

B1114R01ENG2020_Rationale_COVID19_English

Please enter these characters in the following text field.

The fields marked with * are required.